Comanagement of Thyroid Eye Disease for the Ophthalmology and Optometry Provider
This activity is supported by an educational grant from Horizon Therapeutics USA, Inc.
Overview
Provider Statement
This continuing education activity is provided by 
Support Statement
This activity is supported by an educational grant from Horizon Therapeutics USA, Inc.
Activity Description
Thyroid eye disease (TED) is a multifactorial autoimmune disorder characterized by a spectrum of signs and symptoms. Collaborative efforts among ophthalmologists, endocrinologists, neuro-ophthalmologists, oculoplastic surgeons, optometrists, and other specialists are necessary to improve patient evaluation as well as clinical and surgical decision-making. Thyroid eye disease is frequently misdiagnosed, due to both its heterogeneous clinical presentation and lack of understanding on the part of clinicians regarding the relationship between TED and hyperthyroidism. Misdiagnosis can place patients at risk, because management of TED is most effective during the initial, active phase of the disease. However, differential diagnosis can be achieved with the assistance of imaging, and early treatment may limit disfigurement and reduce vision loss. Ophthalmology and optometry providers should be knowledgeable about the presentation of patients with TED as well as the available surgical and nonsurgical treatments. The Comanagement of Thyroid Eye Disease for the Ophthalmology and Optometry Provider monograph will highlight the multidisciplinary and interprofessional approaches that can improve the overall management of patients with TED as well as the treatment of coexisting ocular conditions.
Target Audience
The intended audience for this activity is ophthalmologists, oculoplastic surgeons, neuro-ophthalmologists, optometrists, physician associates, nurse practitioners, and other healthcare professionals involved in the management of patients with thyroid eye disease (TED).
Learning Objectives
Upon successful completion of this activity, participants should be better able to:
- Explore new insights pertaining to the etiology and pathogenesis of thyroid eye disease (TED).
- Employ methods and modalities that can improve the differential diagnosis of TED.
- Detail current and emerging non-surgical management strategies that may improve outcomes in patients with TED.
- Identify surgical practices and procedures used to treat patients with TED.
- Incorporate best practices for managing ocular conditions that may coexist with TED.
Activity Co-Chairs
Gary J. Lelli, Jr., MD
Vice Chair & Associate Professor of Ophthalmology
Director of Ophthalmic Plastic and Reconstructive Surgery
Co-chair, Quality and Patient Safety in Ophthalmology
Weill Cornell Medicine
Department of Ophthalmology
New York, NY
Terry J. Smith, MD
Frederick G.L. Huetwell Professor
Ophthalmology and Visual Sciences
Professor of Internal Medicine
University of Michigan Medical School
Ann Arbor, MI
Faculty
Ana G. Alzaga Fernandez, MD
Assistant Professor of Ophthalmology
Weill Cornell Medicine
New York-Presbyterian Lower Manhattan Hospital
New York, NY
César A. Briceño, MD
Assistant Dean of Diversity and Cultural Affairs
Associate Professor of Clinical Ophthalmology
Advisor Dean
Perelman School of Medicine, University of Pennsylvania
Medical Director, Scheie Eye Institute at Penn Presbyterian Medical Center
Co-Director, Scheie Eye Institute Thyroid Eye Disease Program
Penn Presbyterian Medical Center
Philadelphia, PA
Monte Del Monte, MD, FAAO, FAAP
Active Emeritus Skillman Professor of Pediatric Ophthalmology
Active Emeritus Professor of Pediatrics and Communicable Diseases
Past Director of Pediatric Ophthalmology and Strabismus
WK Kellogg Eye Center
University of Michigan Medical School
Ann Arbor, MI
Kyle J. Godfrey, MD, FACS
Assistant Professor of Ophthalmology
Director, Ophthalmology Residency Program
Ophthalmic Plastic, Reconstructive, and Orbital Surgery Service
Departments of Ophthalmology and Neurological Surgery
Weill Cornell Medicine and New York Presbyterian Hospital
New York, NY
Kira L. Segal, MD
Eltraself
Florham Park, NJ
Edward Wladis, MD, ASOPRS
Professor and Chair
Department of Ophthalmology
Albany Medical College
Albany, NY
Medical Writer
Valerie Zimmerman, PhD
Planners/Reviewers
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
Linda A. Giarraputo, BS, PA-C
Walter O. Whitley, OD, MBA, FAAO
Accreditation
In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. This activity will also award credit for optometry (COPE) if the requirements necessary for credit are met.
Credit Designation
Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Vindico Medical Education designates this enduring activity for a maximum of 1.0 COPE credit hours. Optometrists should claim only the credit commensurate with the extent of their participation in the activity.
COPE Course Number: 89469-SD
COPE Activity Number: 127669
Vindico Medical Education has been authorized by the American Academy of Physician Associates (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.5 AAPA Category 1 CME credits. Approval is valid until January 30, 2025. PAs should only claim credit commensurate with the extent of their participation.
Nurse practitioners can apply for AMA PRA Category 1 Credit(s)™ through the American Academy of Nurse Practitioners Certification Board (AANPCB). AANPCB will accept AMA PRA Category 1 Credit(s)™ from organizations accredited by ACCME.
This enduring material is approved for 1 year from the date of original release, January 31, 2024, to January 30, 2025.
How to Participate in This Activity and Obtain CE Credit
To participate in this activity, you must read the objectives, answer the polling and pretest questions, view the content, and complete the posttest and evaluation. Provide only one (1) correct answer for each question. A satisfactory score is defined as answering 70% of the posttest questions correctly. Upon receipt of the completed materials, if a satisfactory score on the posttest is achieved, Vindico Medical Education will issue an AMA PRA Category 1 Credit(s)™ Certificate, COPE CE Certificate, or AAPA Category 1 CME Certificate.
Disclosures
Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.
The articles in this monograph were composed by medical writer Valerie Zimmerman, PhD, based on the presentations of Drs. Alzaga-Fernandez, Briceño, Del Monte, Godfrey, Lelli, Segal, Smith, and Wladis during a live/virtual meeting held November 18, 2023. The content of this e-monograph has been approved by each of the faculty individually as an accurate representation of their presentations.
Activity Co-Chairs and Faculty report the following relevant financial relationship(s)
Gary J. Lelli, Jr., MD
Advisor: Horizon
Consultant: Horizon
Terry J. Smith, MD
Royalties or Patent Beneficiary: (paid to institution): Horizon
Advisor: Horizon, Hunghui, Viridian
Consultant: Horizon, Hunghui, Viridian
Individual Stocks and Stock Options: Viridian
Ana G. Alzaga Fernandez, MD
No relevant financial relationships to disclose.
César A. Briceño, MD
Consultant: Horizon
Monte Del Monte, MD, FAAO, FAAP
No relevant financial relationships to disclose.
Kyle J. Godfrey, MD, FACS
No relevant financial relationships to disclose.
Kira L. Segal, MD
Consultant: Horizon
Edward Wladis, MD, ASOPRS
Employee or Executive Role: Praxis Biotechnology*
*This activity does not discuss the business lines or products of the employer.
Medical Writer reports the following relevant financial relationship(s)
Valerie Zimmerman, PhD
No relevant financial relationships to disclose.
Planners/Reviewers report the following relevant financial relationship(s)
Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.
Linda A. Giarraputo, BS, PA-C
No relevant financial relationships to disclose.
Walter O. Whitley, OD, MBA, FAAO
No relevant financial relationships to disclose.
Vindico Medical Education staff report the following relevant financial relationship(s)
No relevant financial relationships to disclose.
Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.
Unlabeled and Investigational Usage
The audience is advised that this continuing education activity may contain references to unlabeled uses of FDA-approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.
Copyright Statement
Created and published by Vindico Medical Education, 6900 Grove Road, Building 100, Thorofare, NJ 08086-9447. Telephone: 856-994-9400; Fax: 856-384-6680. Printed in the USA. Copyright © 2024 Vindico Medical Education. All rights reserved. No part of this publication may be reproduced without written permission from the publisher. The material presented at or in any Vindico Medical Education continuing education activity does not necessarily reflect the views and opinions of Vindico Medical Education. Neither Vindico Medical Education nor the faculty endorse or recommend any techniques, commercial products, or manufacturers. The faculty/authors may discuss the use of materials and/or products that have not yet been approved by the FDA. All readers and continuing education participants should verify all information before treating patients or utilizing any product.
Procedures for Reporting Copyright Infringement
If you suspect that any content in this activity violates your copyright, you can request the removal of such content or restrict access to it by getting in touch with our designated copyright agent (as outlined below). To do so, kindly provide the following details:
- Specify the copyrighted work you believe has been infringed upon.
- Describe the work and, if possible, include the location (e.g., URL) of an authorized version of the work.
- Share your name, address, telephone number, and, if available, your email address.
- Assert that you genuinely believe that the use of the materials in question is not authorized by the copyright owner, its agent, or the law.
- Confirm that the information you have provided is accurate and send an attestation, "under penalty of perjury," that you either are the copyright owner or have the authority to act on behalf of the copyright owner.
- Provide a signature or its electronic equivalent from the copyright holder or a representative authorized to act on their behalf.
Our agent for copyright issues relating to this web activity is as follows:
Vindico Medical Education, LLC
Attn: Faith Bantivoglio
6900 Grove Road, Building 300
Thorofare, NJ 08086
fbantivoglio@vindicocme.com
or call: 856-994-9400, ext. 614
CE Questions?
Contact us at cme@vindicoCME.com